Molina Healthcare, Inc.
Molina Healthcare, Inc. is classed by the SEC under Hospital & Medical Service Plans (industry code 6324), based in Long Beach, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $45 billion and a profit of $472 million (its filed statements).
vs its business-model standard
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a insurance business: prior from its industry code (SEC 6324, Hospital & Medical Service Plans); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 5.8 out of ten, 9 of 9 metrics filed: past 6.5 out of ten, present 6.2 out of ten, future 3.8 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
- Surviving crises (past): 6.5 out of ten. No warning events in its filings since 2017. 65th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Track record (past): 2.6 out of ten. +11% a year over 10 filed years; profitable in 9 of 10. 26th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Shareholder treatment (past): 8.5 out of ten. Share count shrank 3.3% a year. 100% of cash flow returned. Insiders: 4 sales, 1 purchases. 85th percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Financial health (present): 6.3 out of ten. ROE 12%: 12¢ of profit per shareholder dollar. Leverage 74%: owes 74¢ per asset dollar. 63rd percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Industry position (present): 4.8 out of ten. bottom 48% of 10 in its family; net margin 1%. 48th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Leadership (present): 8.1 out of ten. top 19% of 10 in its family for leadership; chief executive since 2017. 81st percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
- Room to expand (future): 3.2 out of ten. bottom 32% of 10 in its family for room to expand. 32nd percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Growth drivers (future): 5.2 out of ten. top 48% of 10 in its family for growth drivers. 52nd percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Expectations vs reality (future): 3.2 out of ten. bottom 32% of 10 in its family for expectations against reality. 32nd percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-10 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-07-23 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-07-22 (on EDGAR). Newest filing: Form 4, 2026-10-02. Filings on record since 2002. Read from EDGAR 2026-10-12.
Who runs it
Zubretsky, Joseph M (President & CEO); Keim, Mark Lowell (Chief Financial Officer); Woys, James (Chief Operating Officer); Barlow, Jeff D. (Chief Legal Officer); Hebert, Maurice (Chief Accounting Officer); Bacon, Debra (EVP, Medicaid); Brasier, Barbara L (director); Grohowski, Leo P (director); Lockhart, Stephen H (director); Orlando, Steven J (director); and 5 more. 15 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-10-02.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.